Molecular characterization of the antithrombin III tours deficiency-Reference-Cited by-同舟云学术

Molecular characterization of the antithrombin III tours deficiency

Published:1987-01 Issue:1 Volume:45 Page:115-121
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Duchange Nathalie,Chasse Jean-François,Cohen Georges N.,Zakin Mario M.

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. The site in human antithrombin for functional proteolytic cleavage by human thrombin;Bjork;FEBS Lett.,1981

2. Isolation and sequence characterization of a cDNA clone of human antithrombin III;Chandra,1983

3. Mechanism of the anticoagulant action of heparin;Bjork;Mol. and Cell. Biochem.,1982

4. Antithrombin III Toyama : replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin binding ability;Koide,1984

5. Antithrombin III Basel;Chang,1986

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LOOKING BACK;Annual Review of Microbiology;2005-10-01

2. A Lifetime with Microbes;Comprehensive Biochemistry;2005

3. Lysine Residue 114 in Human Antithrombin III Is Required for Heparin Pentasaccharide-mediated Activation;Journal of Biological Chemistry;1997-03

4. Requirement of Lysine Residues Outside of the Proposed Pentasaccharide Binding Region for High Affinity Heparin Binding and Activation of Human Antithrombin III;Journal of Biological Chemistry;1996-08

5. A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice;Gene;1995-04